Source: Tribune India

The use of hydroxychloroquine to treat coronavirus patients has become highly politicised in the US but it is used widely in India, a top White House official has said, asserting the latest research which showed that the anti-malarial drug is highly effective in the early stages of Covid-19.

“It’s the politicisation of this medicine by the mainstream media and portions of the medical community that somehow made this a battle between President (Donald) Trump and them and created this undue fear and hysteria over a drug, a medicine that has been used for over 60 years relatively safely and is regularly prescribed to pregnant women if they are going to a malaria zone,” White House Office of Trade and Manufacturing Policy Director Peter Navarro told reporters.

“The idea that this is a dangerous drug is just silly, but if you ask the American people based on the media’s coverage of it, that is kind of the state of play right now,” he said.

Navarro said a day earlier four doctors at the Detroit Hospital System filed a request for emergency use authorisation for hydroxychloroquine. The request was for three things.

“One, for early treatment use in a hospital setting. Number two, treatment between a doctor and his patient in an outpatient setting. Three, not just as a therapeutic but also as a possible prophylaxis for preventative use,” he said.

This request to the FDA comes on the heels of the publication of their study in the Journal of Infectious Diseases last week that showed an astonishing 50 per cent reduction in the mortality rate for patients taking hydroxychloroquine, Navarro said.

“Give hydroxy a chance, and please don’t contribute to hydroxy hysteria because if it’s prescribed under the supervision of a doctor, the odds that it can harm you are way, way smaller than the odds that it can help you,” Navarro said.

“This has become highly politicised, but India uses this widely for prophylaxis. There are a number of studies which point to this actually working,” Navarro said.

The official said if he were to show any kind of symptoms, he would first ask his doctor whether hydroxychloroquine is appropriate. “And then I wouldn’t hesitate to take it,” he said.

He said if one looks at the 14-day arc of the virus from the beginning of symptoms, the first seven days are critical: when a person may have fever, dry cough, possibly a profound sense of fatigue.

“At that point, your lungs are still intact, and the virus is not appreciably spread to the rest of your organs. Hydroxychloroquine, based on the science in articles like the one that originally appeared in 2005 in the Journal of Virology, works in a therapeutic way by raising the alkalinity of your cells which slows the replication of the virus and also can kill the virus,” he said.

It also has an anti-inflammatory effect, which is why it is used for rheumatoid arthritis, and the drug can, therefore, also help manage what is called the cytokine storm, he said.








Related: Hydroxychloroquine & Covid-19: India and France, a cruel comparison

Journal of Medicine Says HCQ + Zinc Reduces COVID Deaths

“COVID-19 AND HYDROXYCHLOROQUINE” I DO NOT REGRET ANYTHING “PROFESSOR RAOULT”

HCQ Peer-reviewed: Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection

Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk COVID-19 infection includes HCQ & Ivermectin

Melbourne doctors urge officials to consider hydroxychloroquine, ivermectin in fight against COVID-19

Facebook Oversight Board admits Facebook was wrong to censor information about Hydroxychloroquine

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Lorigo shared with TrialSite that once doctors learn of all of the studies around the world, and start doing their own homework, they become more open-minded, factoring in the risk-reward analysis. Especially if elderly high risk patients present advanced COVID-19, Lorigo has personally seen the drug potentially contribute to saving the lives of clients. Interestingly, the attorney reports that it would appear that hospital administrations are the most recalcitrant to the idea, even if the patients and the ICU doctor are in support.

Read More »

The Chloroquine Wars Part XIV – How to Rig Research: Surgisphere Part I

It was in these very moments in late May when public health officials lost all credibility—a credibility that cannot be restored without major changes taking place. Despite most evidence pointing to a likelihood of HCQ efficacy, they made their call on the back of data supposedly tucked away in a database that nobody had verified, declared it definitive, then swiftly pushed for policy changes around the world.

Read More »